{"nct_id":"NCT01868997","title":"Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease","status":"COMPLETED","status_verified_date":"2024-12","start_date":"2013-07","start_date_type":"ACTUAL","primary_completion_date":"2016-03","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}